Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Sun Pharmaceutical Industries Ltd. closed 13.23% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

The market needs to reclaim and sustain above the 20-day EMA to witness a further northward journey in the upcoming sessions.

Stock Market Today: Indian equities rebounded strongly on Tuesday, 15 July, snapping a four-day losing streak as broad-based ...

Nifty rose above 25,100 and Sensex gained 76 points, recovering from earlier losses led by sectoral strength.Stock-Specific ...

Discover India's groundbreaking ESG framework for the healthcare sector, aimed at guiding sustainable investments and ...

A new study published in the Canadian Medical Association Journal (CMAJ) confirms what many suspected: obesity rates in Canada have surged since the onset of the pandemic. Prior to 2020, the trend was ...

Healthcare and pharma companies like Dr Reddy's Laboratories, Laurus Labs Ltd, Alembic Pharmaceuticals Ltd and Sun Pharma are ...

A Japanese man was sentenced Wednesday to three and a half years in prison in China on espionage charges, according to the ...

Trump pharma and chip tariffs may start this month, sparking price hikes, inflation, and global trade ripples.

Shardul Nautiyal, Mumbai Wednesday, July 16, 2025, 08:00 Hrs [IST] ...

A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.